These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31673850)

  • 1. Neointimal characteristics comparison between biodegradable-polymer and durable-polymer drug-eluting stents: 3-month follow-up optical coherence tomography light property analysis from the RESTORE registry.
    Kobayashi T; Sotomi Y; Suzuki S; Hamanaka Y; Nakatani S; Dijkstra J; Onuma Y; Serruys PW; Sakata Y; Hirayama A; Higuchi Y
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):205-215. PubMed ID: 31673850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early vessel healing after implantation of biodegradable-polymer and durable-polymer drug-eluting stent: 3-month angioscopic evaluation of the RESTORE registry.
    Suzuki S; Sotomi Y; Kobayashi T; Hamanaka Y; Nakatani S; Shiojima I; Sakata Y; Hirayama A; Higuchi Y
    Int J Cardiovasc Imaging; 2019 Jun; 35(6):973-980. PubMed ID: 30874980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very early neointimal coverage of new biodegradable polymer drug-eluting stent compared with durable polymer everolimus-eluting stent evaluated by optical frequency domain imaging.
    Kobayashi N; Ito Y; Yamawaki M; Araki M; Sakai T; Sakamoto Y; Mori S; Tsutsumi M; Nauchi M; Honda Y; Tokuda T; Makino K; Shirai S; Hirano K
    Int J Cardiovasc Imaging; 2018 Apr; 34(4):515-522. PubMed ID: 29159531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Difference of vascular healing between bioabsorbable-polymer and durable-polymer new generation drug-eluting stents: an optical coherence tomographic analysis.
    Matsuhiro Y; Nakamura D; Shutta R; Kawamura A; Nakamura H; Okamoto N; Matsunaga-Lee Y; Yano M; Egami Y; Sakata Y; Nishino M; Tanouchi J
    Int J Cardiovasc Imaging; 2021 Apr; 37(4):1131-1141. PubMed ID: 33165669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative assessment of three drug eluting stents with different platforms but with the same biodegradable polymer and the drug based on quantitative coronary angiography and optical coherence tomography at 12-month follow-up.
    Gil RJ; Bil J; Legutko J; Pawłowski T; Gil KE; Dudek D; Costa RA
    Int J Cardiovasc Imaging; 2018 Mar; 34(3):353-365. PubMed ID: 28965166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An optical coherence tomography study of neointimal morphology and strut coverage at different time intervals from implantation of biodegradable polymer-coated sirolimus-eluting stents.
    Legutko J; Gil RJ; Buszman PE; Kaluza GL; Mintz GS; Roleder T; Krol M; Wojdyla R; Pawlowski T; Brzezinski M; Kondys M; Skwarna B; Jakala J; Zasada W; Partyka L; Dudek D
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):302-309. PubMed ID: 29027737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.
    Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A propensity score-matched comparison of biodegradable polymer vs second-generation durable polymer drug-eluting stents in a real-world population.
    Zhao YJ; Teng M; Khoo AL; Ananthakrishna R; Yeo TC; Lim BP; Loh JP; Chan MY
    Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29316284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra-stent tissue evaluation within bare metal and drug-eluting stents > 3 years since implantation in patients with mild to moderate neointimal proliferation using optical coherence tomography and virtual histology intravascular ultrasound.
    Kitabata H; Loh JP; Pendyala LK; Omar A; Ota H; Minha S; Magalhaes MA; Torguson R; Chen F; Satler LF; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2014 Apr; 15(3):149-55. PubMed ID: 24767313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of late-acquired stent malapposition of drug eluting stents with second generation permanent and biodegradable polymer coatings-A prospective, randomized comparison using optical coherence tomography.
    Roth C; Gangl C; Dalos D; Delle-Karth G; Neunteufl T; Berger R
    J Interv Cardiol; 2018 Dec; 31(6):780-791. PubMed ID: 30479028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravascular imaging comparison of two metallic limus-eluting stents abluminally coated with biodegradable polymers: IVUS and OCT results of the DESTINY trial.
    Costa JR; Chamié D; Abizaid AA; Ribeiro E; Meireles GC; Prudente M; Campos CA; Castro JP; Costa R; Lemos PA
    Int J Cardiovasc Imaging; 2017 Feb; 33(2):161-168. PubMed ID: 27714601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of endothelial shear stress between ultrathin strut bioresorbable polymer drug-eluting stent vs durable-polymer drug-eluting stent post-stent implantation: An optical coherence tomography substudy from BIOFLOW II.
    Beyene S; Tufaro V; Garg M; Gkargkoulas F; Calderon AT; Safi H; Waksman R; Windecker S; Torii R; Melaku GD; Bulant CA; Bourantas CV; Blanco PJ; Garcia-Garcia HM
    Cardiovasc Revasc Med; 2024 Apr; 61():26-34. PubMed ID: 38042738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial Assessment of Strut Coverage of Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months After Stent Implantation by Optical Frequency Domain Imaging: The DISCOVERY 1TO3 Study (Evaluation With OFDI of Strut Coverage of Terumo New Drug Eluting Stent With Biodegradable Polymer at 1, 2, and 3 Months).
    Chevalier B; Smits PC; Carrié D; Mehilli J; Van Boven AJ; Regar E; Sawaya FJ; Chamié D; Kraaijeveld AO; Hovasse T; Vlachojannis GJ
    Circ Cardiovasc Interv; 2017 Dec; 10(12):. PubMed ID: 29246909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The OCT-ORION Study: A Randomized Optical Coherence Tomography Study Comparing Resolute Integrity to Biomatrix Drug-Eluting Stent on the Degree of Early Stent Healing and Late Lumen Loss.
    Lee SWL; Tam FCC; Lam SCC; Kong SL; Shea CP; Chan KKW; Wong MKL; Chan MPH; Wong AYT; Yung ASY; Lam YM; Zhang LW; Wu KKY; Mintz GS; Maehara A
    Circ Cardiovasc Interv; 2018 Apr; 11(4):e006034. PubMed ID: 29654119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparable neointimal healing in patients with stable coronary lesions and acute coronary syndrome: 3-month optical coherence tomography analysis.
    Hamanaka Y; Sotomi Y; Kobayashi T; Omatsu T; Dijkstra J; Sakata Y; Hirayama A; Hirata A; Higuchi Y
    Int J Cardiovasc Imaging; 2021 Jul; 37(7):2095-2105. PubMed ID: 33591475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early vascular healing with rapid breakdown biodegradable polymer sirolimus-eluting versus durable polymer everolimus-eluting stents assessed by optical coherence tomography.
    Tada T; Byrne RA; Schuster T; Cuni R; Kitabata H; Tiroch K; Dirninger A; Gratze F; Kaspar K; Zenker G; Joner M; Schömig A; Kastrati A
    Cardiovasc Revasc Med; 2013; 14(2):84-9. PubMed ID: 23352095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents.
    El-Hayek G; Bangalore S; Casso Dominguez A; Devireddy C; Jaber W; Kumar G; Mavromatis K; Tamis-Holland J; Samady H
    JACC Cardiovasc Interv; 2017 Mar; 10(5):462-473. PubMed ID: 28279314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neointimal tissue characteristics following sirolimus-eluting stent implantation: OCT quantitative tissue property analysis.
    Hou J; Jia H; Liu H; Han Z; Yang S; Xu C; Schmitt J; Zhang S; Yu B; Jang IK
    Int J Cardiovasc Imaging; 2012 Dec; 28(8):1879-86. PubMed ID: 22422037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neointimal tissue characterization after implantation of drug-eluting stents by optical coherence tomography: quantitative analysis of optical density.
    Nishino S; Sakuma M; Kanaya T; Nasuno T; Tokura M; Toyoda S; Abe S; Nakamura D; Tanaka K; Attizzani GF; Bezerra HG; Costa MA; Inoue T
    Int J Cardiovasc Imaging; 2019 Nov; 35(11):1971-1978. PubMed ID: 31218524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.